March 29, 2021
Jonathan Bernstein, MD, University of Cincinnati allergies, speaks with Reuters Health about a new study suggesting hormone replacement therapy increasing the risk of severe asthma in asthmatic women.
December 4, 2020
Margaret Powers-Fletcher, MD, of the UC Division of Infectious Diseases was interviewed by several media outlets about the COMPASS study she is leading.
December 1, 2020
Donald Lynch, MD, assistant professor of cardiovascular health and disease in the University of Cincinnati College of Medicine, is partnering with researchers in Missouri and Georgia to create a smartphone app that delivers COVID-19 information tailored to Black communities.
December 1, 2020
Jarelle Marshall, the first patient dosed in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience.
December 2, 2020
UC is joining a nationwide study to examine the impact of COVID-19 on communities across the United States. The Community Prevalence of SARS-CoV-2 Study (COMPASS) is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health (NIH).
December 1, 2020
Northern Kentucky businessman Carl Fox is taking part in UC's Trailblazer study and is telling his story to WCPO-TV, Channel 9. The TRAILBLAZER study aims to change the parts of a patient’s white blood cells that HIV latches onto, and is led by Dr. Carl Fichtenbaum, a professor in the Division of Infectious Diseases in the Department of Internal Medicine at the University of Cincinnati College of Medicine.
December 9, 2020
Children with epilepsy with no previous psychiatric diagnosis have alarmingly high rates of suicidal thoughts and behaviors, new research suggests. UC's Michael Privitera weighs in.
December 11, 2020
Louito Edje, MD, associate dean of medical education at the University of Cincinnati College of Medicine and UC Medical Center, speaks with CNBC about her participation in a Phase 3 clinical trial for SARS-CoV-2 vaccine after three of her relatives died from the coronavirus. UC is one of approximately 90 sites in the country to host a trial for the mRNA-1273 vaccine developed by the National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.
December 11, 2020
Matthew de Gannes is one of 38 students in the College of Medicine who will earn degrees during the virtual 2020 fall commencement ceremonies set for Dec. 11 and 12. The college will grant 14 doctoral, 23 master’s and one bachelor’s degree. UC is awarding a total of 2,457 degrees to 2,348 students during fall commencement. Some UC programs allow students to earn dual degrees.
December 10, 2020
Dustin Calhoun, MD, of the Department of Emergency Medicine in the UC College of Medicine, was interviewed by the Wall Street Journal about how the rollout of COVID-19 vaccines would work.